[Efficacy and safety of systemic treatments using immune checkpoint inhibitors for advanced hepatocellular carcinoma].

Furuse Junji

Department of Medical Oncology, Kyorin University Faculty of Medicine.

Nihon Shokakibyo Gakkai Zasshi. 2021;118(5):400-406. doi: 10.11405/nisshoshi.118.400.

Abstract

摘要

相似文献

Nihon Shokakibyo Gakkai Zasshi. 2021;118(5):400-406. doi: 10.11405/nisshoshi.118.400.

Biomed Pharmacother. 2020 Dec;132:110797. doi: 10.1016/j.biopha.2020.110797. Epub 2020 Oct 14.

Gut. 2020 Oct;69(10):1904-1906. doi: 10.1136/gutjnl-2019-320116. Epub 2019 Dec 18.

Nat Rev Gastroenterol Hepatol. 2021 Feb;18(2):95-96. doi: 10.1038/s41575-020-00405-1.

Zhonghua Gan Zang Bing Za Zhi. 2021 Jun 20;29(6):600-603. doi: 10.3760/cma.j.cn501113-20191010-00368.

J Formos Med Assoc. 2021 Jan;120(1 Pt 1):1-4. doi: 10.1016/j.jfma.2020.07.009. Epub 2020 Jul 11.

Int J Mol Sci. 2020 Aug 31;21(17):6302. doi: 10.3390/ijms21176302.

World J Gastroenterol. 2021 Mar 14;27(10):919-927. doi: 10.3748/wjg.v27.i10.919.

Hepatobiliary Pancreat Dis Int. 2020 Feb;19(1):91-93. doi: 10.1016/j.hbpd.2019.09.011. Epub 2019 Oct 25.

J Hepatol. 2022 Feb;76(2):262-264. doi: 10.1016/j.jhep.2021.11.021. Epub 2021 Nov 26.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。